
Boston Scientific Corporation BSX
$ 48.02
-1.89%
Annual report 2025
added 02-17-2026
Boston Scientific Corporation P/S Ratio 2011-2026 | BSX
Annual P/S Ratio Boston Scientific Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.63 | 9.26 | 6.73 | 5.31 | 5.13 | 5.06 | 5.63 | 5.26 | 4.24 | 3.86 | 3.14 | 2.66 | 2.55 | 1.42 | 1.19 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 9.26 | 1.19 | 4.47 |
P/S Ratio of other stocks in the Medical devices industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Cutera
CUTR
|
0.939 | - | -10.19 % | $ 1.99 M | ||
|
EDAP TMS S.A.
EDAP
|
0.936 | - | - | $ 162 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
5.44 | - | - | $ 1.77 B | ||
|
Avinger
AVGR
|
0.339 | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
10.3 | - | - | $ 3.31 B | ||
|
Eargo
EAR
|
0.456 | - | - | $ 10.2 M | ||
|
Lianluo Smart Limited
LLIT
|
409 | - | 24.59 % | $ 44.8 M | ||
|
Allied Healthcare Products
AHPI
|
0.894 | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
22 | - | -5.86 % | $ 30.6 M | ||
|
ClearPoint Neuro
CLPT
|
8.55 | $ 13.62 | 0.24 % | $ 386 M | ||
|
Apollo Endosurgery
APEN
|
5.24 | - | - | $ 475 M | ||
|
Alphatec Holdings
ATEC
|
2.7 | $ 8.14 | -1.45 % | $ 1.22 B | ||
|
Aziyo Biologics
AZYO
|
1.09 | - | 1.37 % | $ 20.5 M | ||
|
BioSig Technologies
BSGM
|
183 | - | 37.08 % | $ 85.7 M | ||
|
BIOLASE
BIOL
|
0.0039 | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
0.204 | - | - | $ 16.4 M | ||
|
IRIDEX Corporation
IRIX
|
0.315 | $ 1.13 | 0.9 % | $ 19.1 M | ||
|
Cardiovascular Systems
CSII
|
2.55 | - | 0.15 % | $ 844 M | ||
|
Helius Medical Technologies
HSDT
|
670 | $ 1.44 | -2.7 % | $ 31.7 M | ||
|
CryoLife, Inc.
CRY
|
3.58 | - | -4.14 % | $ 702 M | ||
|
CHF Solutions, Inc.
CHFS
|
0.19 | - | 1.15 % | $ 34.5 M | ||
|
Cytosorbents Corporation
CTSO
|
0.94 | $ 0.42 | -1.42 % | $ 26.1 M | ||
|
LivaNova PLC
LIVN
|
2.74 | $ 77.65 | 0.62 % | $ 4.24 B | ||
|
OrthoPediatrics Corp.
KIDS
|
1.85 | $ 18.43 | -0.35 % | $ 432 M | ||
|
Pulmonx Corporation
LUNG
|
0.805 | $ 1.49 | -2.94 % | $ 60.6 M | ||
|
Delcath Systems
DCTH
|
3.83 | $ 11.48 | -1.8 % | $ 411 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
1.88 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
8.25 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
2.96 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
266 | - | - | $ 111 M | ||
|
LENSAR
LNSR
|
1.22 | $ 5.69 | - | $ 68 M | ||
|
Dynatronics Corporation
DYNT
|
0.0712 | - | 14.99 % | $ 929 K | ||
|
Orthofix Medical
OFIX
|
0.598 | $ 9.75 | -1.22 % | $ 386 M | ||
|
Electromed
ELMD
|
2.73 | $ 37.12 | 2.29 % | $ 314 M | ||
|
MiMedx Group
MDXG
|
1.86 | $ 3.66 | -1.48 % | $ 541 M | ||
|
Butterfly Network
BFLY
|
9.7 | $ 5.43 | 5.85 % | $ 1.34 B | ||
|
Intersect ENT, Inc.
XENT
|
9.12 | - | - | $ 955 M | ||
|
Second Sight Medical Products
EYES
|
44.4 K | - | -0.97 % | $ 54.4 M | ||
|
Myomo
MYO
|
0.828 | $ 1.53 | 15.91 % | $ 64 M | ||
|
GBS
GBS
|
0.812 | - | -0.57 % | $ 7.12 M | ||
|
Globus Medical
GMED
|
4.24 | $ 80.92 | -1.94 % | $ 10.9 B | ||
|
Insulet Corporation
PODD
|
6.7 | $ 151.38 | -5.16 % | $ 10.6 B | ||
|
Profound Medical Corp.
PROF
|
10.3 | $ 6.74 | -1.17 % | $ 204 M | ||
|
CONMED Corporation
CNMD
|
0.959 | $ 35.72 | -3.09 % | $ 1.11 B | ||
|
Inspire Medical Systems
INSP
|
1.93 | $ 42.28 | 0.24 % | $ 1.24 B | ||
|
Integer Holdings Corporation
ITGR
|
1.61 | $ 92.4 | -1.67 % | $ 3.21 B | ||
|
Invacare Corporation
IVC
|
0.133 | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
8.05 | $ 85.69 | -2.09 % | $ 50.1 B | ||
|
Sintx Technologies
SINT
|
6.78 | $ 2.09 | -1.18 % | $ 5.8 M |